These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 23036986

  • 1. Evidence for risk of cardiomyopathy with hydroxychloroquine.
    Sumpter MD, Tatro LS, Stoecker WV, Rader RK.
    Lupus; 2012 Dec; 21(14):1594-6. PubMed ID: 23036986
    [No Abstract] [Full Text] [Related]

  • 2. Hydroxychloroquine: a treatable cause of cardiomyopathy.
    Abbasi S, Tarter L, Farzaneh-Far R, Farzaneh-Far A.
    J Am Coll Cardiol; 2012 Aug 21; 60(8):786. PubMed ID: 22898072
    [No Abstract] [Full Text] [Related]

  • 3. New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.
    Soong TR, Barouch LA, Champion HC, Wigley FM, Halushka MK.
    Hum Pathol; 2007 Dec 21; 38(12):1858-63. PubMed ID: 18061791
    [Abstract] [Full Text] [Related]

  • 4. Should patients on hydroxychloroquine have their eyes examined regularly?
    Shipley M, Silman A.
    Br J Rheumatol; 1997 May 21; 36(5):514-5. PubMed ID: 9189050
    [No Abstract] [Full Text] [Related]

  • 5. Hydroxychloroquine-induced restrictive cardiomyopathy: a case report.
    Dogar MU, Shah NN, Ishtiaq S, Shah PN, Shah P, Mathew S, Vittorio TJ.
    Postgrad Med J; 2018 Mar 21; 94(1109):185-186. PubMed ID: 29353247
    [No Abstract] [Full Text] [Related]

  • 6. Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.
    Yogasundaram H, Putko BN, Tien J, Paterson DI, Cujec B, Ringrose J, Oudit GY.
    Can J Cardiol; 2014 Dec 21; 30(12):1706-15. PubMed ID: 25475472
    [Abstract] [Full Text] [Related]

  • 7. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
    Reynaert S, Setterfield J, Black MM.
    J Eur Acad Dermatol Venereol; 2006 Apr 21; 20(4):487-8. PubMed ID: 16643169
    [No Abstract] [Full Text] [Related]

  • 8. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M.
    J Rheumatol; 1999 Sep 21; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract] [Full Text] [Related]

  • 9. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C, Sperber K, Shapiro DL, Aronow WS, Chao CP, Ash JY.
    Expert Opin Drug Saf; 2011 Sep 21; 10(5):705-14. PubMed ID: 21417950
    [Abstract] [Full Text] [Related]

  • 10. Hydroxychloroquine myopathy.
    Richards AJ.
    J Rheumatol; 1998 Aug 21; 25(8):1642-3. PubMed ID: 9712114
    [Abstract] [Full Text] [Related]

  • 11. Successful desensitization for hydroxychloroquine anaphylaxis.
    Donado CD, Díez EM.
    J Rheumatol; 2010 Sep 21; 37(9):1975-6. PubMed ID: 20810530
    [No Abstract] [Full Text] [Related]

  • 12. A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing.
    Houpt JB.
    J Rheumatol; 1999 Sep 21; 26(9):1864-6. PubMed ID: 10493661
    [No Abstract] [Full Text] [Related]

  • 13. Hyperpigmentation of the skin due to hydroxychloroquine.
    Rood MJ, Vermeer MH, Huizinga TW.
    Scand J Rheumatol; 2008 Sep 21; 37(2):158. PubMed ID: 18415776
    [No Abstract] [Full Text] [Related]

  • 14. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis.
    Unübol M, Ayhan M, Guney E.
    J Clin Rheumatol; 2011 Jan 21; 17(1):46-7. PubMed ID: 21169846
    [No Abstract] [Full Text] [Related]

  • 15. [The everyday clinician. A wolf in sheep's clothing].
    Théophile.
    Rev Med Brux; 2011 Jan 21; 32(5):490. PubMed ID: 22165530
    [No Abstract] [Full Text] [Related]

  • 16. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
    Azimian M, Gultekin SH, Hata JL, Atkinson JB, Ely KA, Fuchs HA, Mobley BC.
    J Clin Rheumatol; 2012 Oct 21; 18(7):363-6. PubMed ID: 23047537
    [Abstract] [Full Text] [Related]

  • 17. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Wolfe F, Marmor MF.
    Arthritis Care Res (Hoboken); 2010 Jun 21; 62(6):775-84. PubMed ID: 20535788
    [Abstract] [Full Text] [Related]

  • 18. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C, Moroni G.
    Expert Opin Drug Saf; 2017 Mar 21; 16(3):411-419. PubMed ID: 27927040
    [Abstract] [Full Text] [Related]

  • 19. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
    Lai TY, Chan WM, Li H, Lai RY, Lam DS.
    Am J Ophthalmol; 2005 Nov 21; 140(5):794-807. PubMed ID: 16310457
    [Abstract] [Full Text] [Related]

  • 20. [The therapy of systemic lupus erythematosus].
    Ochsendorf FR, Runne U.
    Dtsch Med Wochenschr; 1997 Jul 04; 122(27):877. PubMed ID: 9280702
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.